Sales 2026 by Business Segment

Sales 2026 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: March 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Pharmaceutical Product Distribution

          

Drug Wholesale

49.94M 33.08M 47M 119M 118M

CAPEX

-2.91K -704 - - -449

Gross Profit

5.98M 3.6M 4.88M 3.76M 3.96M

D&A

22.07K 31.22K 36K 57.52K 155K

Operating Income

3.13M 910K 2.35M -1.08M -2.14M

Online Drug Retail and Pharmacies

          

Online Pharmacy

30.22M 32.39M 31.86M 1.11M 14.29M

Gross Profit

3.6M 3.88M 3.61M 82.19K 796K

D&A

- - - - 209K

Operating Income

-659K -828K -1.63M 45.33K 271K

Medicinal Chemicals and Botanical Products

          

Operating Income

-178K -3.06K - - -

D&A

- - - - -

Drug Stores and Pharmacies

          

Retail Drugstores

84.23M 83.35M 75.68M - -

CAPEX

-297K -303K - - -

Gross Profit

26.94M 26.8M 22.62M - -

D&A

1.23M 687K 754K - -

Operating Income

-4.99M -21M -4.25M - -

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: March 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

People's Republic of China (PRC)

164M 149M 155M 120M 132M

Total Assets

106M 90.97M 95.06M 64.48M 69.03M

Interest Expense

-262K -65.85K -13.6K - -67.07K

Income Tax Expense

1.1M 395K 62.86K 504K -99.1K

D&A

1.2M 699K 5.37M 6.02M 364K

CAPEX

-306K -312K -857K -615K -449

Gross Profit

36.52M 34.28M 31.11M 3.84M 4.75M

Net Income

-3.19M -21.14M -4.23M 10.19M -1.25M

EBT

-2.1M -20.74M -4.17M -951K -1.35M

Operating Income

-2.69M -20.93M -3.53M -1.04M -1.87M